Excellent session titled “Beyond the Scope: Noninvasive Monitoring in Bladder Cancer”, chaired by @KeyanSalari and @Scarps_kristen at #BCANTT25! Grateful for the opportunity to present our lab’s work here. @pradeep198212 @MayoRadOnc @BladderCancerUS

Thrilled to join JCO PO as Associate Editor! Excited to contribute to the journal's important work in disseminating high-quality cancer research. @JCOPO_ASCO

Please join for Virtual Open House on Tues Dec 17th, 7:30-8:30pm EST for the Combined Harvard Medical School Urologic Oncology Fellowship @MGHUrology @BWHUrology Meet fellows, residents, faculty in an open setting. Please use Zoom link: https://t.co/CscfGPz2jX @SUO_YUO @UroOnc

It was a great pleasure and privilege to share our work @MGHUrology and to learn from such an esteemed group @DanaFarberBRCA!

Join us Nov 1 for the one-day CME course, “State of the Art Imaging in the Diagnosis and Management of Prostate Cancer” featuring advances in mpMRI, MRI-US fusion biopsy, PSMA PET imaging, and more. To register: https://t.co/X2AEkHHmzm

🔔Education Opportunity for Patients with #ProstateCancer & Their Families 📆 5/17/24 8amEST (virtual) Here from experts discussing ✴️ Diet/Lifestyle 🚴‍♂️ ✴️ AI 🤖 ✴️ Biochemical Recurrence 📈 ✴️ Genetics 🧬 ✴️ Survivorship ☺️ Register for FREE! ✍🏽 Link: https://t.co/xkF4emlXiZ

@CGM_MGH associate member and @MGHUrology faculty @KeyanSalari & colleagues find integration of family history + germline genetics refines risk stratification to help individualize prostate cancer care. More here: https://t.co/GA6Fz18BGN

Now published in @EurUrolOncol by @KeyanSalari @aethridgeamini et al: MRI-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of PROGRESS @MGHUrology @MGHCancerCenter

Now published in @JCOPO_ASCO by @MGHUrology @KeyanSalari and incoming urology resident @aethridgeamini: Incorporating Genetic Risk Into Prostate Cancer Care: Implications for Early Detection and Precision Oncology

Now published in @JUrology by @UrologyMSK @RichMatulewicz @DrDarrenFeldman et al.: Primary retroperitoneal lymph node dissection for seminoma metastatic to the retroperitoneum https://t.co/Onh8aPuLvx

Looking for practicing urologic oncologists and/or Society of Urologic Oncology fellows motivated to make an impact! https://t.co/l26Qzrvex8

@MGHUrology is looking to hire urologists to treat benign urologic conditions. Those with interest in general urology, endourology/urolithiasis/BPH, reconstructive urology, FMPRS, andrology/infertility please see link below! https://t.co/BTdA9yL9F1

Now published in @JUrology by @MGHUrology @KeyanSalari @AFeldmanMD @DMDahl and rising urology resident @ASchneider035 et al: Impact of an Expanded Definition of Family History on Outcomes of Active Surveillance for Prostate Cancer

Now in @UrologicClinics by @shawndason @JahanMohebali @urochiefmlb @KeyanSalari: Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus

SEMS trial finally published! ⬆️data RPLND for early Stage II Seminoma is efficacious w/ min short & long term morbidity. Collaborators @IUuro @nabiladra @SBoorjian @pcvblack @uroegg @drphil_urology @kellystratton @LuciaNappi4 @Testiscancer @GU_BigWhacks

Several trials in low-volume metastatic #seminoma highlight potential roles for upfront RPLND or novel chemoRT combinations in effort to spare patients long-term treatment toxicities. https://t.co/eGhwdb5l6X #ASCODailyNews #tscsm #GU23 @sophia_kamran @KeyanSalari

Excited to chair this session with Dr. Ayres. Don't miss it! @ASCO #GU23 Sat Feb 18 As an early preview, check out the @MGHCancerCenter GU multiD take on stg 2 seminoma ➡️#ASCODailyNews https://t.co/BUxE6yVLUm w/ Dr. @KeyanSalari (urology), Dr. Saylor (medonc) & myself (rad onc)

Attn prostate cancer pts and those caring for them: Boston PC Support Group meets virtually first Mon PM monthly. 6-7p are subgroups, 7-8p is main speaker. We welcome all across the country and globe! @PCFnews @MPCCoalition @AmericanCancer @RAPCancer #pcsm

Strong representation from @MGHCancerCenter GU oncology -> basically our multiD clinic (in the flesh!) here at #PCFRetreat22 😂⬇️ + others here but not pictured, @RickLee6, @AFeldmanMD, Phil Saylor + Jason Efstathiou!